Cardiovascular Autonomic Control Evaluation Through Cardiac Frequency Variability in Hypertensive Patients
1 other identifier
interventional
36
1 country
1
Brief Summary
Analyzing cardiovascular evaluation measures in the multidisciplinary and in the conventional treatment of hypertensive patients will provide better parameters for comparing the two approaches.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable hypertension
Started Dec 2011
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2013
CompletedFirst Submitted
Initial submission to the registry
July 31, 2014
CompletedFirst Posted
Study publicly available on registry
August 7, 2014
CompletedAugust 7, 2014
August 1, 2014
1.6 years
July 31, 2014
August 6, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from Baseline in Cardiac Frequency Variability at 1 year
Measured at the first appointment and 1 year later
Secondary Outcomes (1)
Change from Baseline in Systolic and Diastolic Blood pressure
Measured at the first appointment and 1 year later
Study Arms (2)
Conventional Group
ACTIVE COMPARATORConventional treatment and follow up
Multidisciplinary Group
EXPERIMENTALMultidisciplinary assistance
Interventions
Multidisciplinary group assistance was effected every two months by all professionals (physician, nurse, dietitian, physiotherapist and psychologist) and consisted in orientations and mechanisms to medication and non-pharmacological adherence (lifestyle changes).
Assistance was effected by physician and nurse and consisted about adapting to the drug
Eligibility Criteria
You may qualify if:
- Above 18 years of age
- Diagnosis of primary hypertension
You may not qualify if:
- Neurological condition
- Cardiac condition
- Renal condition
- Congenital conditions
- Previous myocardial revascularization surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Instituto de Cardiologia do Rio Grande do Sul
Porto Alegre, Rio Grande do Sul, 90620-000, Brazil
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor
Study Record Dates
First Submitted
July 31, 2014
First Posted
August 7, 2014
Study Start
December 1, 2011
Primary Completion
July 1, 2013
Study Completion
July 1, 2013
Last Updated
August 7, 2014
Record last verified: 2014-08